Literature DB >> 25069408

Multiplex pyrosequencing method to determine CYP2C9*3, VKORC1*2, and CYP4F2*3 polymorphisms simultaneously: its application to a Korean population and comparisons with other ethnic groups.

Kyoung-Ah Kim1, Wan-Geun Song, Hae-Mi Lee, Hyun-Jin Joo, Ji-Young Park.   

Abstract

Warfarin is an anticoagulant that is difficult to administer because of the wide variation in dose requirements to achieve a therapeutic effect. CYP2C9, VKROC1, and CYP4F2 play important roles in warfarin metabolism, and their genetic polymorphisms are related to the variability in dose determination. In this study we describe a new multiplex pyrosequencing method to identify CYP2C9*3 (rs1057910), VKORC1*2 (rs9923231), and CYP4F2*3 (rs2108661) simultaneously. A multiplex pyrosequencing method to simultaneously detect CYP2C9*3, VKORC1*2, and CYP4F2*3 alleles was designed. We assessed the allele frequencies of the polymorphisms in 250 Korean subjects using the multiplex pyrosequencing method. The results showed 100 % concordance between single and multiplex pyrosequencing methods, and the polymorphisms identified by pyrosequencing were also validated with the direct sequencing method. The allele frequencies of these polymorphisms in this population were as follows: 0.040 for CYP2C9*3, 0.918 for VKORC1*2, and 0.416 for CYP4F2*3. Although the allele frequencies of the CYP2C9*3 and VKROC1*2 were comparable to those in Japanese and Chinese populations, their frequencies in this Korean population differed from those in other ethnic groups; the CYP4F2*3 frequency was the highest among other ethnic populations including Chinese and Japanese populations. The pyrosequencing methods developed were rapid and reliable for detecting CYP2C9*3, VKORC1*2, and CYP4F2*3. Large ethnic differences in the frequency of these genetic polymorphisms were noted among ethnic groups. CYP4F2*3 exhibited its highest allele frequency among other ethnic populations compared to that in a Korean population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25069408     DOI: 10.1007/s11033-014-3617-4

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  24 in total

1.  Rapid detection of CYP2C18 genotypes by real-time fluorescence polymerase chain reaction.

Authors:  M Mizugaki; M Hiratsuka; Y Agatsuma; Y Matsubara; K Fujii; S Kure; K Narisawa
Journal:  J Pharm Pharmacol       Date:  2000-02       Impact factor: 3.765

2.  Multiplex Pyrosequencing.

Authors:  Nader Pourmand; Elahe Elahi; Ronald W Davis; Mostafa Ronaghi
Journal:  Nucleic Acids Res       Date:  2002-04-01       Impact factor: 16.971

3.  A comparison between SNaPshot, pyrosequencing, and biplex invader SNP genotyping methods: accuracy, cost, and throughput.

Authors:  Nirupma Pati; Valerie Schowinsky; Obrad Kokanovic; Victoria Magnuson; Soumitra Ghosh
Journal:  J Biochem Biophys Methods       Date:  2004-07-30

4.  Assessment of CYP2C19 genetic polymorphisms in a Korean population using a simultaneous multiplex pyrosequencing method to simultaneously detect the CYP2C19*2, CYP2C19*3, and CYP2C19*17 alleles.

Authors:  K-A Kim; W-K Song; K-R Kim; J-Y Park
Journal:  J Clin Pharm Ther       Date:  2010-12       Impact factor: 2.512

5.  VKORC1 and CYP2C9 genotypes and phenprocoumon anticoagulation status: interaction between both genotypes affects dose requirement.

Authors:  T Schalekamp; B P Brassé; J F M Roijers; E van Meegen; F J M van der Meer; E M van Wijk; A C G Egberts; A de Boer
Journal:  Clin Pharmacol Ther       Date:  2006-12-27       Impact factor: 6.875

6.  CYP2C9 polymorphism and warfarin sensitivity in Taiwan Chinese.

Authors:  Herng-Der Chern; Tzuu-Huei Ueng; Yi-Ping Fu; Chun-Wen Cheng
Journal:  Clin Chim Acta       Date:  2006-01-17       Impact factor: 3.786

7.  A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity.

Authors:  Hsiang-Yu Yuan; Jin-Jer Chen; M T Michael Lee; Ju-Chieh Wung; Ying-Fu Chen; Min-Ji Charng; Ming-Jen Lu; Chi-Ren Hung; Chun-Yu Wei; Chien-Hsiun Chen; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Hum Mol Genet       Date:  2005-05-11       Impact factor: 6.150

Review 8.  P-450 metabolites of arachidonic acid in the control of cardiovascular function.

Authors:  Richard J Roman
Journal:  Physiol Rev       Date:  2002-01       Impact factor: 37.312

9.  Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations.

Authors:  Alan H B Wu; Ping Wang; Andrew Smith; Christine Haller; Katherine Drake; Mark Linder; Roland Valdes
Journal:  Pharmacogenomics       Date:  2008-02       Impact factor: 2.533

10.  Haplotype-based case-control study of the human CYP4F2 gene and essential hypertension in Japanese subjects.

Authors:  Zhenyan Fu; Tomohiro Nakayama; Naoyuki Sato; Yoichi Izumi; Yuji Kasamaki; Atsushi Shindo; Masakatsu Ohta; Masayoshi Soma; Noriko Aoi; Mikano Sato; Koichi Matsumoto; Yukio Ozawa; Yitong Ma
Journal:  Hypertens Res       Date:  2008-09       Impact factor: 3.872

View more
  3 in total

1.  Effects of genetic variants on platelet reactivity and one-year clinical outcomes after percutaneous coronary intervention: A prospective multicentre registry study.

Authors:  Hyung Joon Joo; Sung Gyun Ahn; Jae Hyoung Park; Ji Young Park; Soon Jun Hong; Seok-Yeon Kim; WoongGil Choi; HyeonCheol Gwon; Young-Hyo Lim; Weon Kim; Woong Chol Kang; Yun-Hyeong Cho; Yong Hoon Kim; JungHan Yoon; WonYong Shin; Myeong-Ki Hong; Scot Garg; Yangsoo Jang; Do-Sun Lim
Journal:  Sci Rep       Date:  2018-01-19       Impact factor: 4.379

2.  Impact of genetic variants on major bleeding after percutaneous coronary intervention based on a prospective multicenter registry.

Authors:  Jung-Joon Cha; Hyung Joon Joo; Jae Hyoung Park; Soon Jun Hong; Tae Hoon Ahn; Byeong-Keuk Kim; WonYong Shin; Sung Gyun Ahn; JungHan Yoon; Yong Hoon Kim; Yun-Hyeong Cho; Woong Chol Kang; Weon Kim; Young-Hyo Lim; HyeonCheol Gwon; WoongGil Choi; Do-Sun Lim
Journal:  Sci Rep       Date:  2021-01-19       Impact factor: 4.379

3.  Impact of genetic variants on clinical outcome after percutaneous coronary intervention in elderly patients.

Authors:  Jung-Joon Cha; Jae Hyoung Park; Hyung Joon Joo; Soon Jun Hong; Tae Hoon Ahn; Byeong-Keuk Kim; WonYong Shin; Sung Gyun Ahn; JungHan Yoon; Yong Hoon Kim; Yun-Hyeong Cho; Woong Chol Kang; Weon Kim; Young-Hyo Lim; Hyeon Cheol Gwon; Woong Gil Choi; Do-Sun Lim
Journal:  Aging (Albany NY)       Date:  2021-03-12       Impact factor: 5.955

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.